{"result": "{\n    \"title\": \"Glycogen Storage Disease Type III Community\",\n    \"summary\": \"The community is centered around Glycogen Storage Disease Type III (GSDIII) and its associated medical conditions, including fibrosis, hepatomegalia, and various complications arising from the disease. The entities are interconnected through their relationships to GSDIII, highlighting the complexities of managing this metabolic disorder and its impact on patients' health.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the serious health complications associated with GSDIII and its related conditions, which can significantly affect patient quality of life.\",\n    \"findings\": [\n        {\n            \"summary\": \"GSDIII as a central metabolic disorder\",\n            \"explanation\": \"Glycogen Storage Disease Type III (GSDIII) is a key entity in this community, characterized by a deficiency of the enzyme amilo-1,6-glucosidasa. This deficiency disrupts normal glycogen metabolism, leading to various complications, particularly affecting the muscular and hepatic systems. The disorder's impact is profound, as it can result in symptoms such as muscle weakness, hepatomegalia, and fibrosis, which are critical for understanding the health challenges faced by affected individuals. [Data: Entities (985, 986); Relationships (2666, 2678, 2668)]\"\n        },\n        {\n            \"summary\": \"Complications associated with GSDIII\",\n            \"explanation\": \"Patients with GSDIII face multiple complications, including hepatomegalia, fibrosis, and muscle atrophy. Hepatomegalia is a common clinical manifestation of GSDIII, indicating liver enlargement due to the metabolic disorder. Additionally, fibrosis can develop in patients with liver disease related to prolonged parenteral nutrition, highlighting the serious health concerns associated with GSDIII. These complications necessitate careful monitoring and management to improve patient outcomes. [Data: Entities (988, 997); Relationships (2678, 701)]\"\n        },\n        {\n            \"summary\": \"Nutritional management in GSDIII\",\n            \"explanation\": \"Nutritional support is crucial for managing GSDIII, with options such as ketogenic diets and nighttime enteral nutrition being recommended. The ketogenic diet, which is high in fat and low in carbohydrates, may help alleviate some symptoms associated with GSDIII. Additionally, nighttime enteral nutrition is part of the dietary management strategy to maintain glucose levels in patients, emphasizing the importance of tailored nutritional interventions in this community. [Data: Entities (995, 996); Relationships (2675, 2676)]\"\n        },\n        {\n            \"summary\": \"Genetic basis of GSDIII\",\n            \"explanation\": \"The AGL gene, located on chromosome 1p21.2, encodes the enzyme amilo-1,6-glucosidasa, and mutations in this gene are responsible for the development of GSDIII. Understanding the genetic basis of the disorder is essential for diagnosis and potential future therapies. This genetic insight is critical for families affected by GSDIII, as it can inform genetic counseling and management strategies. [Data: Entities (987); Relationships (2667)]\"\n        },\n        {\n            \"summary\": \"Clinical symptoms and monitoring\",\n            \"explanation\": \"Patients with GSDIII exhibit a range of clinical symptoms, including hypoglycemia, hypotonia, and failure to thrive (fallo de medro). Monitoring blood sugar levels is crucial for managing GSDIII, as hypoglycemia is a primary symptom that can lead to severe health issues. The presence of hypotonia affects muscle tone, further complicating the clinical picture. These symptoms highlight the need for comprehensive care and regular monitoring of patients to ensure their well-being. [Data: Entities (989, 993); Relationships (1378, 2669)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n997,FIBROSIS,\"Fibrosis is a medical condition characterized by the thickening and scarring of connective tissue. It can develop in patients who undergo prolonged parenteral nutrition, resulting in irreversible liver damage. Additionally, fibrosis may occur in the liver of patients with Glycogen Storage Disease Type III (GSDIII), leading to complications even in the absence of steatosis. This condition is particularly significant as it represents a complication associated with liver disease, highlighting the potential risks for individuals receiving long-term nutritional support through parenteral means.\",2\r\n988,HEPATOMEGALIA,\"Hepatomegalia is the enlargement of the liver, a condition that can be commonly observed in patients with Glycogen Storage Disease Type III (GSDIII). Additionally, hepatomegalia is a clinical symptom that may manifest in patients suffering from hepatic venous occlusive disease. This condition highlights the liver's response to various underlying health issues, indicating its significance in diagnosing and understanding liver-related diseases.\",2\r\n985,GSDIII,\"Glycogen Storage Disease Type III (GSDIII), also known as Cori disease, is a metabolic disorder characterized by a deficiency of the enzyme amilo-1,6-glucosidase. This deficiency disrupts normal glycogen metabolism, resulting in a range of clinical manifestations. The disorder primarily affects glucose processing, leading to various complications, particularly involving muscular and hepatic systems. Individuals with GSDIII may experience a variety of symptoms related to these complications, highlighting the significant impact of this metabolic disorder on overall health.\",21\r\n992,GLUCONEOGENESIS,\"Gluconeogenesis is a metabolic process that generates glucose from non-carbohydrate substrates. This process is particularly increased in critically ill patients, highlighting its importance in maintaining glucose levels during times of stress or illness.\",2\r\n986,\"AMILO-1,6-GLUCOSIDASA\",\"Amilo-1,6-glucosidasa is an enzyme responsible for glycogen breakdown, and its deficiency leads to GSDIII.\",1\r\n999,ATROFIA MUSCULAR,\"Muscle atrophy is a potential complication in GSDIII patients, resulting from muscle weakness and inactivity.\",1\r\n995,DIETA CETOGÉNICA,\"A high-fat, low-carbohydrate diet that may improve symptoms in GSDIII patients.\",1\r\n989,FALLO DE MEDRO,\"Fallo de medro refers to failure to thrive, a common symptom in children with GSDIII.\",1\r\n987,GEN AGL,\"The AGL gene located on chromosome 1p21.2 encodes the enzyme amilo-1,6-glucosidasa, and mutations in this gene cause GSDIII.\",1\r\n1000,GLUCÓGENO ANÓMALO RAMIFICADO,,1\r\n993,HIPOTONÍA,\"A condition characterized by decreased muscle tone, often seen in patients with GSDIII.\",1\r\n994,MIKARDIOPATÍA HIPERTRÓFICA,\"Hypertrophic cardiomyopathy, a condition affecting the heart muscle, prevalent in nearly 60% of GSDIII patients.\",1\r\n996,NUTRICIÓN ENTERAL NOCTURNA,Nighttime enteral nutrition recommended for maintaining glucose levels in GSDIII patients.,1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n701,NUTRICIÓN PARENTERAL,FIBROSIS,\"Fibrosis can develop in patients with liver disease related to prolonged parenteral nutrition, indicating a serious health concern.\",252\r\n2681,HEPATOMEGALIA,PACIENTES,Los pacientes con enfermedad venoclusiva hepática pueden presentar hepatomegalia como síntoma.,132\r\n2287,GASTROSTOMÍA,GSDIII,Gastrostomía may be necessary for GSDIII patients who require long-term nutritional support,51\r\n2679,GSDIII,HIPERURICEMIA,Hyperuricemia is a rare complication that can occur in GSDIII patients,32\r\n2672,GSDIII,YEYUNOSTOMÍA,Yeyunostomía may be performed for enteral feeding in GSDIII patients needing prolonged nutritional support,29\r\n2670,GSDIII,CIRROSIS,\"Cirrhosis can occur as a long-term complication in some patients with GSDIII, although it is rare\",28\r\n2275,GLUCEMIA,GSDIII,Monitoring blood sugar levels is crucial for managing GSDIII,28\r\n1378,HIPOGLUCEMIA,GSDIII,Hipo-glucemia is a primary symptom in patients with GSDIII,26\r\n2141,HIPERTRIGLICERIDEMIA,GSDIII,Hipertrigliceridemia is a common metabolic complication associated with GSDIII,25\r\n1762,DISLIPIDEMIA,GSDIII,\"Dislipidemia, particularly hypertriglyceridemia, is often observed in GSDIII patients\",24\r\n2678,GSDIII,FIBROSIS,Fibrosis in the liver is a complication associated with GSDIII,23\r\n2671,GSDIII,GLUCONEOGENESIS,Gluconeogenesis helps to maintain blood glucose levels in GSDIII patients despite impaired glycogenolysis,23\r\n2668,GSDIII,HEPATOMEGALIA,Hepatomegalia is a common clinical manifestation of GSDIII,23\r\n1763,SÍNDROME DE OVARIO POLIQUÍSTICO,GSDIII,Polycystic ovary syndrome may develop in female patients with GSDIII,23\r\n2666,GSDIII,\"AMILO-1,6-GLUCOSIDASA\",\"GSDIII is caused by a deficiency of the enzyme amilo-1,6-glucosidasa\",22\r\n2680,GSDIII,ATROFIA MUSCULAR,Muscle atrophy is a significant concern for patients with GSDIII due to muscle weakness,22\r\n2675,GSDIII,DIETA CETOGÉNICA,Ketogenic diets are recommended for managing symptoms in GSDIII patients,22\r\n2669,GSDIII,FALLO DE MEDRO,Fallo de medro is a symptom that can occur in children with GSDIII,22\r\n2667,GSDIII,GEN AGL,Mutations in the AGL gene lead to the development of GSDIII,22\r\n2677,GSDIII,GLUCÓGENO ANÓMALO RAMIFICADO,Abnormal glycogen accumulation is a key feature in the diagnosis of GSDIII,22\r\n2673,GSDIII,HIPOTONÍA,\"Hypotonia is a common symptom associated with GSDIII, affecting muscle tone in patients\",22\r\n2674,GSDIII,MIKARDIOPATÍA HIPERTRÓFICA,Hypertrophic cardiomyopathy is a significant complication in GSDIII patients,22\r\n2676,GSDIII,NUTRICIÓN ENTERAL NOCTURNA,Nighttime enteral nutrition is part of the dietary management for GSDIII,22\r\n2690,GLUCONEOGENESIS,UCI,Gluconeogenesis is increased in critically ill patients in the UCI to provide necessary glucose,21\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}